MicroRNA-532 protects the heart in acute myocardial infarction, and represses prss23, a positive regulator of endothelial-to-mesenchymal transition

Ahmed S. Bayoumi, Jian Peng Teoh, Tatsuya Aonuma, Zhize Yuan, Xiaofen Ruan, Yao Liang Tang, Huabo Su, Neal Lee Weintraub, Il-man Kim

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Aims Acute myocardial infarction (MI) leads to cardiac remodelling and development of heart failure. Insufficient myocardial capillary density after MI is considered a critical determinant of this process. MicroRNAs (miRs), negative regulators of gene expression, have emerged as important players in MI. We previously showed that miR-532-5p (miR-532) is upregulated by the β-arrestin-biased β-adrenergic receptor antagonist (β-blocker) carvedilol, which activates protective pathways in the heart independent of G protein-mediated second messenger signalling. Here, we hypothesize that β2-adrenergic receptor/β-arrestin-responsive miR-532 confers cardioprotection against MI. Methods and results Using cultured cardiac endothelial cell (CEC) and in vivo approaches, we show that CECs lacking miR-532 exhibit increased transition to a fibroblast-like phenotype via endothelial-to-mesenchymal transition (EndMT), while CECs over-expressing miR-532 display decreased EndMT. We also demonstrate that knockdown of miR-532 in mice causes abnormalities in cardiac structure and function as well as reduces CEC proliferation and cardiac vascularization after MI. Mechanistically, cardioprotection elicited by miR-532 is in part attributed to direct repression of a positive regulator of maladaptive EndMT, prss23 (a protease serine 23) in CECs. Conclusions In conclusion, these findings reveal a pivotal role for miR-532-prss23 axis in regulating CEC function after MI, and this novel axis could be suitable for therapeutic intervention in ischemic heart disease.

Original languageEnglish (US)
Pages (from-to)1603-1614
Number of pages12
JournalCardiovascular Research
Volume113
Issue number13
DOIs
StatePublished - Nov 1 2017

Fingerprint

Serine Proteases
MicroRNAs
Myocardial Infarction
Arrestin
Endothelial Cells
Adrenergic Antagonists
Second Messenger Systems
Regulator Genes
GTP-Binding Proteins
Adrenergic Receptors
Myocardial Ischemia
Heart Failure
Fibroblasts
Cell Proliferation
Phenotype
Gene Expression

Keywords

  • Biased G protein-coupled receptor signalling
  • Cardioprotection
  • Endothelial-to-mesenchymal transition
  • MicroRNAs
  • β-Arrestin

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

MicroRNA-532 protects the heart in acute myocardial infarction, and represses prss23, a positive regulator of endothelial-to-mesenchymal transition. / Bayoumi, Ahmed S.; Teoh, Jian Peng; Aonuma, Tatsuya; Yuan, Zhize; Ruan, Xiaofen; Tang, Yao Liang; Su, Huabo; Weintraub, Neal Lee; Kim, Il-man.

In: Cardiovascular Research, Vol. 113, No. 13, 01.11.2017, p. 1603-1614.

Research output: Contribution to journalArticle

Bayoumi, Ahmed S. ; Teoh, Jian Peng ; Aonuma, Tatsuya ; Yuan, Zhize ; Ruan, Xiaofen ; Tang, Yao Liang ; Su, Huabo ; Weintraub, Neal Lee ; Kim, Il-man. / MicroRNA-532 protects the heart in acute myocardial infarction, and represses prss23, a positive regulator of endothelial-to-mesenchymal transition. In: Cardiovascular Research. 2017 ; Vol. 113, No. 13. pp. 1603-1614.
@article{f38e79a1c3a441e69ceae3ab11e5e621,
title = "MicroRNA-532 protects the heart in acute myocardial infarction, and represses prss23, a positive regulator of endothelial-to-mesenchymal transition",
abstract = "Aims Acute myocardial infarction (MI) leads to cardiac remodelling and development of heart failure. Insufficient myocardial capillary density after MI is considered a critical determinant of this process. MicroRNAs (miRs), negative regulators of gene expression, have emerged as important players in MI. We previously showed that miR-532-5p (miR-532) is upregulated by the β-arrestin-biased β-adrenergic receptor antagonist (β-blocker) carvedilol, which activates protective pathways in the heart independent of G protein-mediated second messenger signalling. Here, we hypothesize that β2-adrenergic receptor/β-arrestin-responsive miR-532 confers cardioprotection against MI. Methods and results Using cultured cardiac endothelial cell (CEC) and in vivo approaches, we show that CECs lacking miR-532 exhibit increased transition to a fibroblast-like phenotype via endothelial-to-mesenchymal transition (EndMT), while CECs over-expressing miR-532 display decreased EndMT. We also demonstrate that knockdown of miR-532 in mice causes abnormalities in cardiac structure and function as well as reduces CEC proliferation and cardiac vascularization after MI. Mechanistically, cardioprotection elicited by miR-532 is in part attributed to direct repression of a positive regulator of maladaptive EndMT, prss23 (a protease serine 23) in CECs. Conclusions In conclusion, these findings reveal a pivotal role for miR-532-prss23 axis in regulating CEC function after MI, and this novel axis could be suitable for therapeutic intervention in ischemic heart disease.",
keywords = "Biased G protein-coupled receptor signalling, Cardioprotection, Endothelial-to-mesenchymal transition, MicroRNAs, β-Arrestin",
author = "Bayoumi, {Ahmed S.} and Teoh, {Jian Peng} and Tatsuya Aonuma and Zhize Yuan and Xiaofen Ruan and Tang, {Yao Liang} and Huabo Su and Weintraub, {Neal Lee} and Il-man Kim",
year = "2017",
month = "11",
day = "1",
doi = "10.1093/cvr/cvx132",
language = "English (US)",
volume = "113",
pages = "1603--1614",
journal = "Cardiovascular Research",
issn = "0008-6363",
publisher = "Oxford University Press",
number = "13",

}

TY - JOUR

T1 - MicroRNA-532 protects the heart in acute myocardial infarction, and represses prss23, a positive regulator of endothelial-to-mesenchymal transition

AU - Bayoumi, Ahmed S.

AU - Teoh, Jian Peng

AU - Aonuma, Tatsuya

AU - Yuan, Zhize

AU - Ruan, Xiaofen

AU - Tang, Yao Liang

AU - Su, Huabo

AU - Weintraub, Neal Lee

AU - Kim, Il-man

PY - 2017/11/1

Y1 - 2017/11/1

N2 - Aims Acute myocardial infarction (MI) leads to cardiac remodelling and development of heart failure. Insufficient myocardial capillary density after MI is considered a critical determinant of this process. MicroRNAs (miRs), negative regulators of gene expression, have emerged as important players in MI. We previously showed that miR-532-5p (miR-532) is upregulated by the β-arrestin-biased β-adrenergic receptor antagonist (β-blocker) carvedilol, which activates protective pathways in the heart independent of G protein-mediated second messenger signalling. Here, we hypothesize that β2-adrenergic receptor/β-arrestin-responsive miR-532 confers cardioprotection against MI. Methods and results Using cultured cardiac endothelial cell (CEC) and in vivo approaches, we show that CECs lacking miR-532 exhibit increased transition to a fibroblast-like phenotype via endothelial-to-mesenchymal transition (EndMT), while CECs over-expressing miR-532 display decreased EndMT. We also demonstrate that knockdown of miR-532 in mice causes abnormalities in cardiac structure and function as well as reduces CEC proliferation and cardiac vascularization after MI. Mechanistically, cardioprotection elicited by miR-532 is in part attributed to direct repression of a positive regulator of maladaptive EndMT, prss23 (a protease serine 23) in CECs. Conclusions In conclusion, these findings reveal a pivotal role for miR-532-prss23 axis in regulating CEC function after MI, and this novel axis could be suitable for therapeutic intervention in ischemic heart disease.

AB - Aims Acute myocardial infarction (MI) leads to cardiac remodelling and development of heart failure. Insufficient myocardial capillary density after MI is considered a critical determinant of this process. MicroRNAs (miRs), negative regulators of gene expression, have emerged as important players in MI. We previously showed that miR-532-5p (miR-532) is upregulated by the β-arrestin-biased β-adrenergic receptor antagonist (β-blocker) carvedilol, which activates protective pathways in the heart independent of G protein-mediated second messenger signalling. Here, we hypothesize that β2-adrenergic receptor/β-arrestin-responsive miR-532 confers cardioprotection against MI. Methods and results Using cultured cardiac endothelial cell (CEC) and in vivo approaches, we show that CECs lacking miR-532 exhibit increased transition to a fibroblast-like phenotype via endothelial-to-mesenchymal transition (EndMT), while CECs over-expressing miR-532 display decreased EndMT. We also demonstrate that knockdown of miR-532 in mice causes abnormalities in cardiac structure and function as well as reduces CEC proliferation and cardiac vascularization after MI. Mechanistically, cardioprotection elicited by miR-532 is in part attributed to direct repression of a positive regulator of maladaptive EndMT, prss23 (a protease serine 23) in CECs. Conclusions In conclusion, these findings reveal a pivotal role for miR-532-prss23 axis in regulating CEC function after MI, and this novel axis could be suitable for therapeutic intervention in ischemic heart disease.

KW - Biased G protein-coupled receptor signalling

KW - Cardioprotection

KW - Endothelial-to-mesenchymal transition

KW - MicroRNAs

KW - β-Arrestin

UR - http://www.scopus.com/inward/record.url?scp=85034826939&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034826939&partnerID=8YFLogxK

U2 - 10.1093/cvr/cvx132

DO - 10.1093/cvr/cvx132

M3 - Article

C2 - 29016706

AN - SCOPUS:85034826939

VL - 113

SP - 1603

EP - 1614

JO - Cardiovascular Research

JF - Cardiovascular Research

SN - 0008-6363

IS - 13

ER -